Cardiomyopathy Therapy4 days ago
Capricor Moves Forward With DMD Cardiomyopathy Therapy
Food and Drug Administration (FDA) rejected Capricor Therapeutics is back in the regulatory spotlight with promising data for its investigational cell therapy, Deramiocel, after six months....
